In particular, we focused on luminal breast cancer (LBC) that, as mentioned above, is the breast cancer subtype with the highest frequency of CDKN1B mutations11–13 and chose the MCF-7 cell line as a validated model of LBC. Here, CDKN1B is linked to breast carcinoma.